Texas Senate · 90th Legislature, Regular Session
Official title: Relating to the disclosure by a pharmacy to a patient of the pharmacy's lowest cost cash price for a prescribed drug or biological product.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)90R
SB 272 amends Section 562.003 of the Occupations Code, which covers a pharmacy's disclosure of drug prices to patients. Under the bill, a pharmacy shall disclose the lowest cost cash price at that pharmacy for the drug or biological product prescribed to the patient. The bill's text does not say when or how the pharmacy must give this information, such as whether the patient must ask first. The bill also keeps the rule that applies when a drug's price is lower than the patient's copayment under the patient's prescription drug insurance plan. In that case, the pharmacist shall offer the patient the option of paying the lower price instead of the copayment amount. The bill does not create a new fee, agency, or penalty, and it does not state its cost or purpose, so the fiscal note or bill analysis would be the place to look for those details. The bill takes effect September 1, 2027.
Read the full text below for the definitive meaning.
Each version links to the authoritative document on capitol.texas.gov.
90R1398 AND-D By: Blanco S.B. No. 272 A BILL TO BE ENTITLED AN ACT relating to the disclosure by a pharmacy to a patient of the pharmacy's lowest cost cash price for a prescribed drug or biological product. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 562.003, Occupations Code, is amended to read as follows:
Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A pharmacy shall disclose the lowest cost cash price at that pharmacy for the drug or biological product prescribed to the patient. (b) If the price of a drug or biological product to a patient is lower than the amount of the patient's copayment under the patient's prescription drug insurance plan, the pharmacist shall offer the patient the option of paying for the drug or biological product at the lower price instead of paying the amount of the copayment. SECTION 2. This Act takes effect September 1, 2027.
Source
Each subject links to other 90R bills tagged the same way.
SourceLegiScan (CC BY 4.0)subject tags
SourceTexas Legislative Council (capitol.texas.gov)90R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)90R
No fiscal notes or analyses recorded for this bill.
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →